SMARCB1 and osteosarcoma: They examined 114 specimens from 70 osteosarcoma patients to build a tissue microarray (TMA) and assess the staining of SMARCB1 protein using a straightforward Avidin–Biotin Complex-based immunohistochemically run assay or immunofluorescence on paraffin blocks.